VEGFA and neoplasm: Given that VEGF-mediated signaling pathways are the major drivers of tumor angiogenesis, anti-angiogenic therapy targeting VEGF-dependent signaling to normalize tumor vasculature represents an emerging therapeutic strategy [100].